In a previous study published in 2012,
researchers treated psoriasis patients with antibodies that attack IL - 17A and with a substance, called an antagonist, that acts against tumour necrosis factor, another cytokine strongly implicated in psoriasis.
Not exact matches
Harnessing the power of immune cells,
researchers create a compound that successfully
treats psoriasis in mice.
Previous studies have suggested that IkappaBzeta genetic variations may raise the risk of
psoriasis, so the
researchers hypothesized that lowering this protein with itaconate would
treat psoriasis.
Let me reveals this, according to
researchers you can't
treat psoriasis permanently.